all report title image

VETERINARY DRUGS COMPOUNDING MARKET ANALYSIS

Veterinary Drugs Compounding Market, By Drug Class (CNS Agents, Anti-infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others), By Animal Type (Companion Animals and Livestock Animals), By Formulation (Oral, Injectable, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jun 2024
  • Code : CMI4796
  • Pages :224
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Key Developments

  • In April 2022, The USFDA's Center for Veterinary Medicine released Final Guidance for Industry No. 256 on compounding animal drugs from bulk substances. It outlines when enforcement actions won't be taken, such as for specific prescriptions for non-food-producing animals or sedatives for free-ranging wildlife. The FDA encourages reporting adverse events and emphasizes compliance with state regulations.
  • In August 2022, Vimian Group, a leading provider of digital solutions, made a strategic move to enhance its services for veterinary clinics in Germany by acquiring Heiland GmbH, a prominent online ordering platform. This acquisition marks a pivotal moment in Vimian Group's efforts to digitize its wide-ranging service offerings for veterinary hospitals.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.